QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
GlobeNewswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages QDEL Investors Who Suffered Substantial Losses to Contact its..